Gapping Up:
In reaction to strong earnings/guidance: SCS 7.0%, AKS 6.8%, STAY 5.7%, CAG 5.1%, PAYX 1.6%, ORCL 0.1%, BGCP 0.0%,
M&A news: BMY +1% (BMY to sell its diabetes business to AstraZeneca (AZN); raises Quarterly div by $0.01 to $0.36 per share); BAYRY +0.1% (Bayer AG plans to acquire Norwegian pharmaceutical co Algeta for NOK 362 per share in cash; implies equity value of NOK 17.6 bln (EUR 2.1 bln)
Other news: ALIM +90% (co and FDA Enter Into Labeling Discussions for ILUVIEN, Agree Advisory Committee No Longer Necessary); PSDV +58% (partnered with ALIM, co and FDA Enter Into Labeling Discussions for ILUVIEN, Agree Advisory Committee No Longer Necessary; CDTI +29% (announced that it has received two significant emission reduction product verifications from the U.S. Environmental Protection Agency (the "EPA") for use in heavy duty highway truck engines and off-road engines); OXBT +8.5% (provides a business review and update in conjunction with filing of 2Q2014 financials; in 2014, co anticipates enrolling first patient in the Phase 3 trial for levosimendan in cardiac surgery patients at risk for developing LCOS in July 2014); CCIH +8.3% (still checking); HYGS +8.0% (selected as a participating partner in a DOE project award to supply hydrogen fuel cell modules to the Center for Transportation and the Environment); GILT +7.6% (awarded a project valued at $30 mln as part of the Integracion Amazonica Loreto; awarded $99-million project from Colombia's MINTIC); USU +7.3% (was informed that Department of Energy Prepared to Extend American Centrifuge RD&D Program Three Months) STNG +5.0% (still checking); PERI +4.6% (still checking); TRLA +4.0% (S.A.C. Capital discloses 5.2% passive stake in 13G filing); COG +2.7% (announces agreement to provide natural gas to the Dominion Cove Point LNG Terminal); BBRY +1.3% (announced two appointments that strengthen the Company's strategy, marketing and operations); HALO +2.1% (still checking); CIEN +1.7% (ollowing favorable mention on Mad Money); TSL +0.3% (Trina Solar has been chosen as the sole supplier of 25 MW of modules to Phase III of the 75 MW Bangchak Solar Energy Project in Thailand)
Analyst comments: RMTI +7.9% (Chardan Capital Markets Initiated Coverage with a Buy and $22 tgt); CHTP +2.5% (initiated with a Mkt Outperform at JMP Securities)
M&A news: BMY +1% (BMY to sell its diabetes business to AstraZeneca (AZN); raises Quarterly div by $0.01 to $0.36 per share); BAYRY +0.1% (Bayer AG plans to acquire Norwegian pharmaceutical co Algeta for NOK 362 per share in cash; implies equity value of NOK 17.6 bln (EUR 2.1 bln)
Other news: ALIM +90% (co and FDA Enter Into Labeling Discussions for ILUVIEN, Agree Advisory Committee No Longer Necessary); PSDV +58% (partnered with ALIM, co and FDA Enter Into Labeling Discussions for ILUVIEN, Agree Advisory Committee No Longer Necessary; CDTI +29% (announced that it has received two significant emission reduction product verifications from the U.S. Environmental Protection Agency (the "EPA") for use in heavy duty highway truck engines and off-road engines); OXBT +8.5% (provides a business review and update in conjunction with filing of 2Q2014 financials; in 2014, co anticipates enrolling first patient in the Phase 3 trial for levosimendan in cardiac surgery patients at risk for developing LCOS in July 2014); CCIH +8.3% (still checking); HYGS +8.0% (selected as a participating partner in a DOE project award to supply hydrogen fuel cell modules to the Center for Transportation and the Environment); GILT +7.6% (awarded a project valued at $30 mln as part of the Integracion Amazonica Loreto; awarded $99-million project from Colombia's MINTIC); USU +7.3% (was informed that Department of Energy Prepared to Extend American Centrifuge RD&D Program Three Months) STNG +5.0% (still checking); PERI +4.6% (still checking); TRLA +4.0% (S.A.C. Capital discloses 5.2% passive stake in 13G filing); COG +2.7% (announces agreement to provide natural gas to the Dominion Cove Point LNG Terminal); BBRY +1.3% (announced two appointments that strengthen the Company's strategy, marketing and operations); HALO +2.1% (still checking); CIEN +1.7% (ollowing favorable mention on Mad Money); TSL +0.3% (Trina Solar has been chosen as the sole supplier of 25 MW of modules to Phase III of the 75 MW Bangchak Solar Energy Project in Thailand)
Analyst comments: RMTI +7.9% (Chardan Capital Markets Initiated Coverage with a Buy and $22 tgt); CHTP +2.5% (initiated with a Mkt Outperform at JMP Securities)